Journals / Okmeydanı Tıp Dergisi / 2013 / Cilt: 29 - Sayı: 2

Clinical properties and evaluation of sarcoidosis cases in our center, our 7 years experience

Merkezimizdeki sarkoidoz olgularının klinik özellikleri ve değerlendirilmesi, 7 yıllık tecrübemiz

Pages
67–71
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For an ac- curate diagnosis of sarcoidosis, the multimodality approach including clinical, radiological, and histo- pathological evaluation is recommended.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Sarcoidosis is a systemic granulomatous disease of unknown cause.
📊
Key Findings & Data:For an ac- curate diagnosis of sarcoidosis, the multimodality approach including clinical, radiological, and histo- pathological evaluation is recommended.
💡
Conclusion & Impact:Evaluation were done in terms of results of stage, chest radiography, computed tomography, fiberop- tic bronchoscopy and HRCT findings, sedimentation, WBC,hemoglobin, CRP, ACE, blood calcium and 24- hour urine calcium, ECG and holter findings, eye invol- vement, skin and other extrapulmonary organ invol- vement, and pulmonary function test findings, DLCO, PPD and pathology of the patients.
🔬Design:Research Article
📍Scope:2002 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Sarcoidosis is a systemic granulomatous disease of unknown cause. Although the lung is the most common organ affected with sarcoidosis, the disease may involve any part of the body. For an ac- curate diagnosis of sarcoidosis, the multimodality approach including clinical, radiological, and histo- pathological evaluation is recommended. Because of the varied clinical presentations of sarcoidosis, there is not a standard diagnostic algorithm. Sarcoidosis may resolve spontaneously or remain stable or progress. Its treatment is not standardized, and its prognosis can not be easily predicted. In this study, we aimed to highlight clinical and radiological features, laboratory findings, diagnostic procedures, organ involvement and other characteristics of sarcoidosis cases diagno- sed during 7 years time interval. Material and Methods: In this study 70 patients, 58 (82.9%) being female and 12 (17.1%) being male who had the diagnosis of sarcoidosis at our center from 2002 to 2009 were evaluated retrospectively. Results: The mean age of patients was 43.94 (15-68). Diagnostic methods were clinical radiological: 6, me- diastinoscopy: 30, transbronchial biopsy: 16, bronchial mucosa biopsy: 6, skin biopsies: 8, peripheral LAP bi- opsy: 2, spleen biopsy (splenectomy): 1, thoracotomy: 1. Evaluation were done in terms of results of stage, chest radiography, computed tomography, fiberop- tic bronchoscopy and HRCT findings, sedimentation, WBC,hemoglobin, CRP, ACE, blood calcium and 24- hour urine calcium, ECG and holter findings, eye invol- vement, skin and other extrapulmonary organ invol- vement, and pulmonary function test findings, DLCO, PPD and pathology of the patients.

Özet

Amaç: Sarkoidoz nedeni bilinmeyen sistemik granü- lomatöz bir hastalıktır. akciğerler en yaygın etkilenen organ olmasına rağmen, hastalık vücudun herhangi bir bölümünü tutabilir. Doğru tanı için klinik, radyo- lojik multimodal yaklaşım ve histopatolojik değerlen- dirilme önerilir. Çeşitli klinik seyir nedeni ile, standart tanı algoritması yoktur. Sarkoidoz kendiliğinden dü- zelebilir veya aynı kalabilir veya ilerleyebilir. Tedavisi standart değildir ve prognozu kolayca tahmin edile- mez. Bu çalışmada 7 yıl suresi içinde tanı koyduğumuz sar- koidozlu hastaların, klinik ve radyolojik özellikleri, tanı yöntemleri, laboratuar bulguları, organ tutulum- ları ve diğer karekteristik özellikleri konusunda ki bul- gularımızı aktardık. Gereç ve Yöntem: Bu çalışmada merkezimizde 2002- 2009 yılları arasında sarkoidoz tanısı konulan 58’si (% 82.9) kadın ve 12’ü (% 17.1) erkek toplam 70 hasta retrospektif olarak incelendi. Bulgular: Hastaların yaş ortalaması 43.94 (15-68) idi. Tanı Şekli: Klinik-radyolojik: 6, mediastinoskopi: 30, transbronşiyal biyopsi: 16, bronş mukoza biyopsisi: 6, cilt biyopsisi: 8, periferik LAP biyopsisi: 2, dalak biyop- sisi (splenektomi): 1, torakotomi: 1 idi. Evre, akciğer grafi, bilgisayarlı tomografi, fiberoptik bronkoskopi ve HRCT bulguları, sedimantasyon, WBC, hemoglobin, CRP, ACE, kan kalsiyum ve 24 saatlik idrarda kalsiyum, EKG ve Holter bulgular, göz tutulumu, deri ve diğer akciğer dışı organ tutulumu ve solunum fonksiyon tes- ti bulguları, DLCO, PPD ve patoloji sonuçları açısından değerlendirildi.

🔖

Cite This Article

İÇTEN, S., ALTINTAŞ, N., HELVACI, A., ASLAN, E. (2013). Clinical properties and evaluation of sarcoidosis cases in our center, our 7 years experience. Okmeydanı Tıp Dergisi, Cilt: 29 - Sayı: 2, 67–71. https://ajindex.com/articles/291802

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA 2003
  2. http://dx.doi.org/10.1001/jama.289.24.3300 PMid:12824213 2. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997
  3. http://dx.doi.org/10.1056/NEJM199704243361706 PMid:9110911 3. Hutchinson J. Case of livid papillary psoriasis, In Illust- rations of Clinical Surgery, Vol. I. J&A Churchill. Lon- don 1877, 42-43. 4. Judson MA, Thompson BW, Rabin DL, et al. The diag- nostic pathway to sarcoidosis. Chest 2003
  4. http://dx.doi.org/10.1378/chest.123.2.406 PMid:12576358 5. Judson MA, Baughman RP, Teirstein AS, et al. Defi- ning organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoido- sis Vasc Diffuse Lung Dis 1999
  5. PMid:10207945 6. Tabak L. Sarkoidoz olgularında uzun dönem izlem so- nuçları. Solunum 2001
  6. Musellim B, Kumbasar OO, Ongen G, et al. Epidemi- ological features of Turkish patients with sarcoidosis. Respir Med 2009
  7. http://dx.doi.org/10.1016/j.rmed.2008.12.011 PMid:19181507 8. Bourbonnais JM, Samavati L. Effect of gender on he- alth related quality of life in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2010
  8. PMid:21319591 9. Criado E, Sánchez M, Ramírez J, et al. Pulmonary sar- coidosis: typical and atypical manifestations at high- resolution CT with pathologic correlation. Radiograp- hics 2010
  9. http://dx.doi.org/10.1148/rg.306105512 PMid:21071376 10. Bottaro L, Calderan L, Dibilio D, Mosconi E, Maffes- santi M. Pulmonary sarcoidosis: atypical HRTC featu- res and differential diagnostic problems. Radiol Med 2004
  10. Birnbaum AD, Oh FS, Chakrabarti A, Tessler HH, Gold- stein DA. Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch Ophthalmol 2011
  11. http://dx.doi.org/10.1001/archophthalmol.2011.52 PMid:21482866 12. Rafiei P, Vijayakumar V. Be Aware of Disseminated Sarcoidosis With Diffuse Subcutaneous Nodules on F-18 FDG PET. Clin Nucl Med 2011
  12. e42-44. http://dx.doi.org/10.1097/RLU.0b013e31821739cf PMid:21552015 13. Lagana SM, Moreira RK, Lefkowitch JH. Hepatic gra- nulomas: pathogenesis and differential diagnosis. Clin Liver Dis 2010
  13. http://dx.doi.org/10.1016/j.cld.2010.07.005 PMid:21055685 14. Rizzato G. Extrapulmonary presentation of sarcoido- sis. Curr Opin Pulm Med 2001
  14. http://dx.doi.org/10.1097/0006319